- published: 29 Jul 2016
- views: 92
C-X-C chemokine receptor type 4 (CXCR-4) also known as fusin or CD184 (cluster of differentiation 184) is a protein that in humans is encoded by the CXCR4 gene.
CXCR-4 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1 also called CXCL12), a molecule endowed with potent chemotactic activity for lymphocytes. CXCR4 is one of several chemokine receptors that HIV can use to infect CD4+ T cells. HIV isolates that use CXCR4 are traditionally known as T-cell tropic isolates. Typically, these viruses are found late in infection. It is unclear as to whether the emergence of CXCR4-using HIV is a consequence or a cause of immunodeficiency.
CXCR4 is upregulated during the implantation window in natural and hormone replacement therapy cycles in the endometrium, producing, in presence of a human blastocyst, a surface polarization of the CXCR4 receptors suggesting that this receptor is implicated in the adhesion phase of human implantation.
CXCR4's ligand SDF-1 is known to be important in hematopoietic stem cell homing to the bone marrow and in hematopoietic stem cell quiescence. Until recently, SDF-1 and CXCR4 were believed to be a relatively monogamous ligand-receptor pair (other chemokines are promiscuous, tending to use several different chemokine receptors). Recent evidence demonstrates ubiquitin is also a natural ligand of CXCR4.Ubiquitin is a small (76-amino acid) protein highly conserved among eukaryotic cells. It is best known for its intracellular role in targeting ubiquitylated proteins for degradation via the ubiquitin proteasome system. Evidence in numerous animal models suggests ubiquitin is anti-inflammatory immune modulator and endogenous opponent of proinflammatory damage associated molecular pattern molecules. It is speculated this interaction may be through CXCR4 mediated signalling pathways. MIF is an additional ligand of CXCR4
For more information, visit CancerQuest at http://www.cancerquest.org/targeted-molecular-receptors. The CXCR4 protein is a chemokine receptor that appears to be involved in several different disease processes. First, the receptor seems to guide cancer cell migration during metastasis. Second, the CXCR4 protein is a co-receptor for some forms of HIV. The animation depicts the inhibition of the binding of CXCR4 with its ligand, SDF-1. For further information, visit http://www.cancerquest.org
Molecular Recognition of CXCR4 by a Dual Tropic HIV-1 gp120 V3 Loop P. Tamamis and C.A. Floudas. Biophysical Journal 105 : 1502-1514, 2013. http://www.sciencedirect.com/science/article/pii/S0006349513008734 The V3 loop fragment of HIV-1 gp120 (shown in red color) binds to human coreceptor CXCR4 (showin gray color). The movie shows the gradual stabilization of salt bridges (dashed lines) during the simulation. The HIV-1 gp120 V3 loop residues are renumbered from 1-35.
For more information, visit CancerQuest at http://www.cancerquest.org/how-cancer-spreads-introduction. 3D animation. Best viewed with anaglyph (red/green glasses). This animation shows the spread of cancer via blood vessels. In this case, the final destination is guided by signaling molecules that bind to the migrating cells. In the example shown, the signaling molecules are SDF-1 and the receptor is CXCR4. This is thought to occur in breast cancer and some other cancer types. For further information, visit http://www.cancerquest.org
Video Project by Max Luo and Ivan Ye for Prof. Saven's CHEM251. This video seeks to explain metastatic cancer and the role of CXCR4-CXCL12 signaling in metastasis while highlighting recent progress on illuminating the exact molecular pathways of metastasis.
For additional information visit http://www.cancerquest.org/hyunsuk-shim-interview. To learn more about cancer and watch additional interviews, please visit the CancerQuest website at http://www.cancerquest.org
Visit our website for text version of this Definition and app download. http://www.medicaldictionaryapps.com Subjects: medical terminology, medical dictionary, medical dictionary free download, medical terminology made easy, medical terminology song
Current drug discovery is an expensive, trial-and-error process. Computational methods can potentially decrease both the time and costs involved, but has not proven useful yet. Researchers at UC San Francisco are working to change this. In collaboration with Simbios, they demonstrated that their molecular docking software could identify effective drug leads for the receptor CXCR4, which is involved in both cancer and HIV. Read more about this research: Mysinger, M.M., et al. (2012) Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4. Proceedings of the National Academy of Sciences 109(14):5517-5522.
For additional information visit http://www.cancerquest.org/hyunsuk-shim-interview. To learn more about cancer and watch additional interviews, please visit the CancerQuest website at http://www.cancerquest.org
Pleirxafor es un antagonista del receptor CXCR4 expresado en diferentes tipos de células hematopoyéticas, incluyendo las células madre hematopoyéticas. Actualmente, está indicado su uso en combinación con Factor Estimulante de Colonias de Granulocitos para la movilización de células madre hematopoyéticas al torrente sanguíneo para su posterior cosecha y trasplante autólogo de células madre (médula ósea) en pacientes con Linfoma no Hodgkin y Mieloma Múltiple. Su uso en diferentes tipos de enfermedades oncohematológicas sigue en investigación ya que es un medicamento con un mecanismo de acción innovador y con capacidad de generar muchos cambios en el tratamiento de diferentes tipos de cáncer. Avances en la ciencia... avances por la vida